Two antibodies with purple circles.

Migraine - Research


Preventive treatment for migraine: The present, the future, and the role of monoclonal antibodies

There is no doubt that migraine should be treated; before the
COVID-19 pandemic, migraine ranked second among causes of disability globally, and is a significant source of burden.1 However, questions on how treatment should proceed still remain. As part of the 7th Congress of the European Academy of Neurology, Profs. Zaza Katsarava (University of Essen-Duisberg, Germany), Hans-

Login to register to read this article

If you do not have a Log in, please register to be part of a big community, experience premium content and stay informed about exclusive professional events.

Log In

Not registered yet? Register now